Corresponding to slightly increased choroidal thickness in the untreated eyes with AMD in our study, treatment studies reported a significant reduction in subfoveal choroidal thickness after intravitreal application of anti-vascular endothelial growth factor in eyes with typical neovascular AMD, compared to eyes with polypoidal choroidal vasculopathy27. The gene discussed is VEGFA; the disease is age-related macular degeneration.